Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients

NCT01331915 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

BIOLOGICAL: Theravac

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Collaborators

[object Object]